(423 days)
No
The summary describes a standard negative pressure wound therapy device with a pump, canister, and tubing. There is no mention of AI, ML, or any features that would suggest the use of such technologies for decision-making, data analysis, or adaptive therapy. The performance studies focus on basic device functionality and alarm systems.
Yes
The device is indicated for promoting wound healing by removing fluids and is described as a "Negative Pressure Wound Therapy" device, which directly relates to therapeutic action.
No
The device is described as a suction pump for negative pressure wound therapy to promote wound healing via removal of fluids. Its function is therapeutic, not diagnostic.
No
The device description clearly outlines a physical suction pump device with components like a canister, tubing, and power supply, indicating it is a hardware device with potential embedded software.
Based on the provided text, the RENASYS GO device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is a "suction device (negative pressure wound therapy)" used to "promote wound healing via removal of fluids...". This describes a therapeutic device that acts directly on the wound.
- Device Description: The description details a "lightweight suction pump device intended for wound management via application of continuous or intermittent negative pressure wound therapy". It explains how it creates a closed environment over the wound and removes exudates. This is consistent with a therapeutic device.
- Lack of IVD Characteristics: The text does not mention any of the key characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.) in vitro (outside the body).
- Providing diagnostic information about a patient's health status, disease, or condition.
- Using reagents or assays to detect specific substances.
The device's function is to physically remove fluids from a wound to aid in healing, which is a therapeutic action, not a diagnostic one.
N/A
Intended Use / Indications for Use
The RENASYS GO is indicated for patients who would benefit from a suction device (negative pressure wound therapy) as it may promote wound healing via removal of fluids, including irrigation and body fluids, wound exudates and infectious materials.
Appropriate wound types include:
- Chronic
- Acute
- Traumatic
- Sub-acute and dehisced wounds
- Ulcers (such as pressure or diabetic)
- Partial-thickness burns
- Flaps and grafts
Product codes (comma separated list FDA assigned to the subject device)
OMP
Device Description
The RENASYS GO NPWT device is a modification to predicate device K088375. It is a lightweight suction pump device intended for wound management via application of continuous or intermittent negative pressure wound therapy to the wound for removal of fluids, including wound exudates, irrigation fluids, and infectious materials. The RENASYS GO NPWT device is designed to deliver negative pressure wound therapy to a closed environment over a wound in order to drain exudates from the wound site to help promote wound healing.
The closed environment over the wound is created by applying a sterile foam or gauze wound dressing to the wound site and connecting the sealed wound to the suction pump via a tube that connects to the disposable canister. The suction pump delivers negative pressure wound therapy and removes the exudates from the wound site to the disposable canister.
The device provides negative pressure wound therapy to the wound at a range of pressure settings between 40-200mmHg. The device can operate either by a mains power supply or internal battery.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Tests (Bench)
Testing has been conducted to verify the modifications to the RENASYS GO NPWT device meet design specifications and demonstrate substantial equivalence to the predicate device.
The list below summarizes the bench testing undertaken and successfully completed for the RENASYS GO NPWT device:
- Pumping capacity is equivalent to the predicate device.
- Verification that the device delivers negative pressure wound therapy in a continuous and intermittent operating mode identical to the predicate device.
- Verification of Complete Blockage/Canister Overcapacity alarm functionality using wound fluid designed to simulate chemistry and protein content of real exudate.
- Verification of system performance in foreseeable fault conditions.
- Verification of system performance when running with high air leaks at the dressing site.
- Verification of system performance in worst case scenarios with ranges of exudate viscosity and protein content.
- Verification of Blockage/Canister Over-capacity & Leak Alarm assertion when used in a vertical orientation.
- Verification of Blockage/Canister Over-capacity & Leak Alarm assertion when used in a horizontal face up orientation.
- Verification of Blockage/Canister Over-capacity & Leak Alarm assertion when used in a horizontal face down orientation.
- Verification of Renasys GO performance at increased heights above the wound.
- Verification of O-Ring durability.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4780 Powered suction pump.
(a)
Identification. A powered suction pump is a portable, AC-powered or compressed air-powered device intended to be used to remove infectious materials from wounds or fluids from a patient's airway or respiratory support system. The device may be used during surgery in the operating room or at the patient's bedside. The device may include a microbial filter.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal features a stylized eagle with three lines forming its body and head. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 29, 2016
Smith & Nephew, Inc. Ms. Laura Reynolds Director of Regulatory Affairs 970 Lake Carillon Drive Suite 110 St. Petersburg, Florida 33716
Re: K152163
Trade/Device Name: Renasys Go Regulation Number: 21 CFR 878.4780 Regulation Name: Powered suction pump Regulatory Class: Class II Product Code: OMP Dated: September 26, 2016 Received: September 26, 2016
Dear Ms. Reynolds:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
David Krause -S
for Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known)
K152163
Device Name
RENASYS GO Negative Pressure Wound Therapy Device
Indications for Use (Describe)
The RENASYS GO is indicated for patients who would benefit from a suction device (negative pressure wound therapy) as it may promote wound healing via removal of fluids, including irrigation and body fluids, wound exudates and infectious materials.
Appropriate wound types include:
- · Chronic
- · Acute
- · Traumatic
- · Sub-acute and dehisced wounds
- · Ulcers (such as pressure or diabetic)
- · Partial-thickness burns
- · Flaps and grafts
Type of Use (Select one or both, as applicable)
Z Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.qov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.
3
Image /page/3/Picture/0 description: The image shows the Smith & Nephew logo. The logo consists of a stylized flower-like graphic on the left, followed by the text "We are smith&nephew". The words "We are" are in gray, while "smith&nephew" is in orange.
Wound Management 727 392-1261
F 727 392-6914 or 727 392-0797 Smith & Nephew, Inc. 970 Lake Carillon Drive Customer Care Center: 1 800 876-1261 Suite 300 www.smith-nephew.com St. Petersburg, FL 33716
510(k) Summary
General Information Submitters Name/Address: Smith & Nephew, Inc. 970 Lake Carillon Drive Suite 300 St. Petersburg, FL 33716 Establishment Registration Number: 3006760724 Contact Person: Laura Reynolds Director Regulatory Affairs Phone Number: (727) 686-8736 Date Prepared: September 29, 2016 Device Description RENASYS™ GO Negative Pressure Wound Trade Name: Therapy Device Generic/Common Name: Powered Suction Pump Classification Name: Powered Suction Pump; 21 CFR 878.4780 Product Code: OMP
Predicate Device Information
| Subject Device | Predicate Device | 510k# | Clearance
Date |
|---------------------------------------------------------|---------------------------------------------------------|---------|-------------------|
| RENASYS GO Negative
Pressure Wound Therapy
Device | RENASYS GO Negative
Pressure Wound Therapy
Device | K083375 | 02/25/2009 |
4
Device Description
RENASYS GO Negative Pressure Wound Therapy Device
The RENASYS GO NPWT device is a modification to predicate device K088375. It is a lightweight suction pump device intended for wound management via application of continuous or intermittent negative pressure wound therapy to the wound for removal of fluids, including wound exudates, irrigation fluids, and infectious materials. The RENASYS GO NPWT device is designed to deliver negative pressure wound therapy to a closed environment over a wound in order to drain exudates from the wound site to help promote wound healing.
The closed environment over the wound is created by applying a sterile foam or gauze wound dressing to the wound site and connecting the sealed wound to the suction pump via a tube that connects to the disposable canister. The suction pump delivers negative pressure wound therapy and removes the exudates from the wound site to the disposable canister.
The device provides negative pressure wound therapy to the wound at a range of pressure settings between 40-200mmHg. The device can operate either by a mains power supply or internal battery.
RENASYS GO Canisters
RENASYS GO uses an integral waste canister that is supplied non-sterile, single-use with a volume capacity of 300ml or 750ml. The waste canister is attached to the pump device by two clips on either side of the canister. The canister is permanently sealed to minimize the potential of users coming into contact with exudates. Safety features include a 1.0 micron filter in the top of the canister to resist fluid penetration into the device, as well as a 0.2 micron bacterial filter to prevent the passage of airborne bacteria. Each sealed canister contains a solidifier which acts as a gelling agent to the exudate.
A tube is permanently attached to the bottom of the waste canister through an inlet port. A connector attached to the distal end of the canister tube attaches to the corresponding tubing included in each Smith & Nephew NPWT dressing kit.
The RENASYS GO device is compatible with RENASYS Foam and Gauze dressing kits with Soft Port which were cleared under 510(k) K142979.
Indications for Use
RENASYS GO Negative Pressure Wound Therapy Device
RENASYS GO is indicated for patients who would benefit from a suction device (negative pressure wound therapy) as it may promote wound healing via removal of fluids, including irrigation and body fluids, wound exudates and infectious materials.
Appropriate wound types include:
- . Chronic
- Acute .
5
- Traumatic ●
- Sub-acute and dehisced wounds ●
- Ulcers (such as pressure or diabetic) .
- . Partial-thickness burns
- Flaps and grafts .
The indications for use of the subject device are identical to the predicate, except "Examples of" has been removed from appropriate wound types.
Comparison of Technological Characteristics
The RENASYS GO Negative Pressure Wound Therapy (NPWT) device and canisters that are the subject of this submission are substantially equivalent to the previously cleared versions of the RENASYS GO Negative Pressure Wound Therapy (NPWT) device and canisters. There has been no change to the indications for use, operating principle, mechanism of action or fundamental scientific technology of the predicate device. Generally, software and hardware modifications were made to improve alarm functionality and to meet IEC 60601 3rd Edition requirements. A 750ml canister has been added as an additional option for highly exuding wounds. Thus the subject and predicate devices have substantially equivalent technological characteristics.
Summary Comparison between New and Predicate Devices
| | Subject Device: | Predicate Device:
510(k)# K083375 |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | 510(k)#K152163 | |
| Trade Name: | RENASYS GO NPWT | RENASYS GO NPWT |
| Indications for Use: | The RENASYS GO is
indicated for patients who
would benefit from a
suction device (negative
pressure wound therapy)
as it may promote wound
healing via removal of
fluids, including irrigation
and body fluids, wound
exudates and infectious
materials.
Appropriate wound types
include:
• Chronic
• Acute
• Traumatic
• Sub-acute and
dehisced wounds
• Ulcers (such as
pressure or | The RENASYS GO is
indicated for patients who
would benefit from a
suction device (negative
pressure wound therapy)
as it may promote wound
healing via removal of
fluids, including irrigation
and body fluids, wound
exudates and infectious
materials.
Examples of appropriate
wound types include:
• Chronic
• Acute
• Traumatic
• Sub-acute and
dehisced wounds
• Ulcers (such as
pressure or |
RENASYS GO NPWT
6
| | Subject Device:
510(k)#K152163 | Predicate Device:
510(k)# K083375 |
|-----------------------------|------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------|
| Trade Name: | RENASYS GO NPWT
diabetic)
• Partial-thickness
burns
• Flaps and grafts | RENASYS GO NPWT
diabetic)
• Partial-thickness
burns
• Flaps and grafts |
| Principle of Operation | Same as predicate | Therapy unit delivers
software controlled
negative pressure wound
therapy to the wound site. |
| Operating Time
(Battery) | Same as predicate | 20 hours Therapy |
| Negative Pressure
Range | Same as predicate | 40-200mmHg |
| Components | • Therapy unit
• 300mL canister
• 750mL canister | • Therapy unit
• 300mL canister |
Table of Modifications
| Modification | Reason For Change | Verification Testing
Performed |
|------------------------------------------|------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Hardware and Software
modifications | To improve alarm functionality | Software validation and
comprehensive
verification testing was
completed which
demonstrated
acceptable device
performance |
| Software and labeling
revisions | IEC 60601 3rd Edition
Compliance | Software verification and
usability studies were
completed which
demonstrated
acceptable device
performance. Electrical
safety testing in
accordance with IEC
60601 3rd Edition
standards has been
successfully completed. |
| Addition of RENASYS
GO 750ml canister | Additional option for highly
exuding wounds | Comprehensive
verification was
completed which
demonstrated
acceptable device
performance |
| Design change to | To improve robustness of | Comprehensive |
7
| Modification | Reason For Change | Verification Testing
Performed |
|----------------------------------------------------------------------------|-----------------------------------------------------|-----------------------------------------------------------------------------------------|
| canister and
qualification of alternate
materials of
construction | device and aid
manufacturability | verification was
completed which
demonstrated
acceptable device
performance |
| Markings on canister
added to include
change indicator | To aid/alert user to
appropriate change interval | Usability studies were
completed to verify
labeling changes |
Non-Clinical Tests (Bench)
RENASYS GO Negative Pressure Wound Therapy Device
Testing has been conducted to verify the modifications to the RENASYS GO NPWT device meet design specifications and demonstrate substantial equivalence to the predicate device.
The list below summarizes the bench testing undertaken and successfully completed for the RENASYS GO NPWT device:
- . Pumping capacity is equivalent to the predicate device.
- Verification that the device delivers negative pressure wound therapy in a continuous and intermittent operating mode identical to the predicate device.
- . Verification of Complete Blockage/Canister Overcapacity alarm functionality using wound fluid designed to simulate chemistry and protein content of real exudate.
- Verification of system performance in foreseeable fault conditions.
- Verification of system performance when running with high air leaks at the dressing site.
- Verification of system performance in worst case scenarios with ranges of exudate viscosity and protein content.
- Verification of Blockaqe/Canister Over-capacity & Leak Alarm assertion when . used in a vertical orientation.
- Verification of Blockage/Canister Over-capacity & Leak Alarm assertion when ● used in a horizontal face up orientation.
- Verification of Blockage/Canister Over-capacity & Leak Alarm assertion when ● used in a horizontal face down orientation.
- . Verification of Renasys GO performance at increased heights above the wound.
- . Verification of O-Ring durability.
The software documentation in this submission has been assembled according to the recommendations in the FDA document. Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, dated May 11, 2005. The software Level of Concern has been evaluated and determined to be Moderate, and appropriate documentation included, as recommended by the cited FDA guidance.
8
Device complies with the following standards:
- . ISO 14971:2012 Medical Devices - Application of Risk Management to Medical Devices
- . ISO 15223-1:2012 Medical devices - Symbols to be used with medical device labels, labelling, and information to be supplied Part 1: General requirements. (General)
- ISO 15223-2:2010 Medical devices Symbols to be used with medical device ● labels, labelling, and information to be supplied-Part 2: Symbol development, selection and validation. (General)
- . IEC 60601-1:2005 (3rd Edition). Medical Electrical Equipment - Part 1: General Requirements for Safety
- . IEC 60601-1-6:2010 (3rd Edition) Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
- IEC 60601-1-8:2006 (2nd Edition) Medical electrical equipment Part 1-8: ● General requirements for basic safety and essential performance - Collateral Standard: General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical
- IEC 60601-1-11:2010 (1st Edition) Medical Electrical Equipment Part 1-11: ● General requirements for basic safety and essential performance - Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment
- IEC 62366:2007 (1st Edition) Medical devices Application of usability . engineering to medical devices
- ANSI/AAMI ES60601-1:2005 Version (R2012) Medical Electrical Equipment -Part 1: General Requirements for Basic Safety and Essential Performance
- RTCA/DO-160G, Environmental Conditions and Test Procedures for Airborne Equipment, Sections 18, 19, 20.4, 20.5, 21.4, 21.5.
- ANSI/AAMI HE75:2009 Human Factor Engineering-Design of Medical Devices
- IEC CISPR-25 2008, 3rd Ed. Vehicles, Boats and Internal Combustion Engines-● Radio Disturbance Characteristics.
- EN 50121-3-2 Part 3-2:2015 Railway Applications Electromagnetic Compatibility
Conclusions
In establishing substantial equivalence to the currently marketed predicate device, Smith & Nephew, Inc. evaluated the indications for use, materials, technology, product specifications and energy requirements of the device. Performance testing and electrical safety testing has been successfully completed to demonstrate that the RENASYS GO NPWT device and canisters are substantially equivalent to the predicate devices for the intended use.